Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Current Ratio Over TimeElevated
Percentile Rank100
3Y CAGR+30.2%
5Y CAGR+45.3%
Year-over-Year Change
Current ratio (current assets / current liabilities)
3Y CAGR
+30.2%/yr
vs -8.3%/yr prior
5Y CAGR
+45.3%/yr
Recent deceleration
Acceleration
+38.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
6.5x
Strong expansion
Streak
5 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 27.40 | +21.1% |
| 2024 | 22.63 | +27.8% |
| 2023 | 17.71 | +42.7% |
| 2022 | 12.41 | +5.4% |
| 2021 | 11.77 | +178.6% |
| 2020 | 4.23 | -48.8% |
| 2019 | 8.24 | -52.9% |
| 2018 | 17.52 | +3546.9% |
| 2017 | 0.48 | - |